RecruitingEarly Phase 1NCT07033845
Pharmacokinetic Study of Topical Phenylephrine
Sponsor
Applied Biology, Inc.
Enrollment
24 participants
Start Date
Jun 30, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Pharmacokinetic Study of Topical Phenylephrine
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years
Inclusion Criteria5
- Healthy females, age 18-55
- BMI: 18-30 kg/m²
- Fitzpatrick Skin Types I-IV (to standardize absorption risk)
- Scalp free from irritation, dermatologic disease, or damage
- Able to refrain from using other topical scalp products
Exclusion Criteria5
- History of cardiovascular disease, hypertension, or arrhythmia
- Scalp infections, wounds, or significant hair loss
- Recent use of medications that interfere with CYP enzymes or adrenergic systems
- Known sensitivity to phenylephrine or ethanol
- Positive drug screen or abnormal ECG at screening
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPhenylephrine
Topical Phenylephrine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07033845
Related Trials
Taste Alterations Study
NCT066694161 location
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
NCT067588301 location
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
NCT067259531 location
Prevention of Alopecia in Patients With Localised Breast Cancer
NCT060115253 locations
Scalp Cooling in MBC
NCT049865792 locations